LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Cardiometabolic Diseases: Molecular Basis, Early Detection of Risks, and Management provides detailed information on all aspects of metabolic dysfunctions and associated risks for… Read more
LIMITED OFFER
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Cardiometabolic Diseases: Molecular Basis, Early Detection of Risks, and Management provides detailed information on all aspects of metabolic dysfunctions and associated risks for cardiometabolic diseases, including a thoughtful discussion of cellular and molecular mechanisms involved in the progression of metabolic risks, approaches for the early detection, and robust management of metabolic risks. Written by a team of expert contributors, this book is useful reading for researchers and clinicians interested on recent advances in etiology of cardiometabolic diseases, the latest noninvasive approaches for diagnosis, risk assessment tools, therapeutic strategies, and also aspects of prevention of cardiometabolic diseases.
Researchers interested on the complexity of cardiometabolic diseases, cardiovascular fellows, and endocrinologists, Public health workers, medical students and pharma companies
GR
UD
Undurti N. Das is an M.D. in Internal Medicine from Osmania Medical College, Hyderabad, India; a Fellow of the National Academy of Medical Sciences, India, and Shanti Swaroop Bhatnagar prize awardee. Apart from clinical work, he is researching the role of polyunsaturated fatty acids, cytokines, nitric oxide, free radicals, and anti-oxidants in cancer, inflammation, metabolic syndrome, schizophrenia, sepsis, rheumatological conditions and autisms. His current interests include the epidemiological and molecular aspects of autism, diabetes mellitus, hypertension, cardiovascular diseases and metabolic syndrome. Dr. Das was formerly scientist at Efamol Research Institute, Kentville, Canada; Professor of Medicine at Nizam’s Institute of Medical Sciences, Hyderabad, India and Research Professor of Surgery and Nutrition at SUNY (State University of New York) Upstate Medical University, Syracuse, USA. At present, he is the Chairman and Research Director of UND Life Sciences LLC, USA, and serves as a consultant to both Indian and USA based biotech and pharmaceutical companies. Undurti Das is the Founding Editor of the international journal: Lipids in Health and Disease; and serves on the editorial board of another 10 international journals. Dr Das has more than 500 international publications and has been awarded 5 USA patents.